Medicinal cannabis in Germany - Business Report

168 Confidential __________________________________________________________________________________ Of great importance is which governing coalition will be in office in Germany in the next few years, because the parties' attitudes towards the medical use and personal use of Cannabis are quite differ- ent. Abolition of the permit requirement, partial liberalisation of "recrea- tional use". Abolition of the permit requirement, partial liberalisation of "recrea- tional use". Abolition of the permit requirement, liberalisation of "recreational use". Liberalisation of "recreational use" only in pilot projects. No further liberalisation Unknown Table 16: Parties and their attitude towards the use of Cannabis The facts and analyses in the previous sections of this report describe a market in transition. Alt- hough in its largest market segment, Cannabis prescription drugs, less than two years old, the market for medicinal Cannabis already reached secured sales of approx. 75 million euros in its first full year 2018, because it is reimbursed by the SHI. Including the private health insurance expenses for medical Cannabis and the hospital sector, probably even around 90 million euros. And the discernible dynamic over the months of 2018 promises further increases in future years. In fact, there are several estimates and forecasts concerning the market for medical Cannabis in Germany. They come less from medical professionals than from the economic environment of the companies, investors and experts interested in investments and returns on the cultivation and trade of medical Cannabis.